Mass spectrometry
Intact or subunit mass, peptide mapping, HRMS, LC-MS/MS, or MALDI-TOF selected for the product and structural question.
Facilities & Platforms
Match the analytical platform to the product question.
Platform selection follows the product format, sample constraints, comparison plan, analytical question, and review needs of each project.
Analytical platform categories
Select platforms from the product question, not from a fixed menu.
The categories below reflect methods used in approved capability materials. Specific platform availability, sample requirements, method suitability, and delivery boundaries are confirmed during project scoping.
Chromatography & electrophoresis
SEC, RP-HPLC, CE-SDS, iCIEF, or IEX selected around purity, size, charge, and heterogeneity questions.
Biophysical & functional analysis
SEC-MALS/AUC, DLS/MFI, CD, fluorescence, DSC/DSF, FTIR, SPR/BLI, ELISA, or cell-based assays as scoped.
Workflow-led narrative
Evaluate facilities through the work they need to support.
Project fit
Match the analytical question, sample constraints, and review needs to an appropriate workflow before naming a platform.
Traceability
Define sample identity, handling, data lineage, review points, and the boundary of each handoff.
Technical review
Keep interpretation tied to the agreed question, comparison context, and evidence limitations.
What shapes platform fit
Bring the practical context that affects the analytical route.
- Product format and development stage
- Available sample types, quantities, and reference materials
- Known observations, risks, or comparison groups
- Handling, storage, and timing constraints
- Expected use of the results and review needs